Is continuous warm retrograde blood cardioplegia completely safe for coronary artery surgery?

P. Mikaeloff,O. Jegaden,P. Montagna,J. Ossete,P. Desseigne,A. Eker,R. Loire,R. Rossi

DOI: https://doi.org/10.1016/1010-7940(94)90037-X

IF: 4.534

European Journal of Cardio-Thoracic Surgery

Abstract:

What problem does this paper attempt to address?

Chronic inflammation and gastrointestinal cancer

Satoshi Ida,Masayuki Watanabe,Hideo Baba

DOI: https://doi.org/10.4103/2394-4722.166994

2015-01-01

Journal of Cancer Metastasis and Treatment

Abstract:Chronic inflammation has been identified as an important risk factor in the development of the gastrointestinal (GI) tract cancers, and the underlying molecular mechanisms have been studied extensively. Chronic inflammation is able to trigger cellular events to promote malignant transformation of normal epithelial cells in the GI tract to cancer. Host inflammation responses in carcinogenesis are through multiple mechanisms such as reactive oxygen and nitration species from mononuclear phagocytes and leukocytes, immune response and pro-inflammatory cytokines. Nuclear factor-κB (NF-κB) has been considered as the central mediator of the immune response. Activation of NF-κB by phosphorylation leads to translocation of NF-κB protein to the nucleus, and in turn regulates the transcription of several pro-inflammatory cytokines and chemokines. Furthermore, chronic inflammation creates an environment for genomic and epigenetic changes. In this review, we summarize the important molecular mechanisms that link chronic inflammation and GI tract cancer, including esophageal, gastric and colonic cancers, focusing on infective and noninfective agents such as gastroesophageal reflux disease, Helicobacter pylori gastritis and inflammatory bowel disease.
From Inflammation to Cancer: the Molecular Basis

A. Korniluk,O. Koper,H. Kemona,V. Dymicka-Piekarska

DOI: https://doi.org/10.1142/9789814343602_0004

2012-01-01

Abstract:The link between inflammation and cancer has been recognized for a long time. Instead of a simple summation of molecular events in single cells, carcinogenesis results from the complex interaction of cancer-stem cells and tumor-permissive microenvironment. The tumor-permissive microenvironment is featured by the suppression of cell-mediated immune response, pro-angiogenesis and inhibition of apoptosis. A number of soluble bioactive factors including various cytokines and growth factors, produced by tumor cells or non-tumor cells, contribute to the formation of such an inflammatory microenvironment by the persistent activation of multiple intracellular signaling pathways such as NF-kappa B and STAT3 pathways.Carcinogenesis is a multi-stage process resulting from the accumulation of many genetic and epigenetic changes. However, it is more than a simple summation of molecular events in single cells. The role of inflammatory microenvironment in carcinogenesis was well recognized, eventually revolutionizing our strategies to cancer treatment and prevention.
The Epigenetic Aspects of Gastric Cancer

Hongchuan Jin,Xian Wang

DOI: https://doi.org/10.5772/16569

2012-01-01

Abstract:Genetic susceptibility seems to play an important role in some gastric cancers. In some rare cases, gastric cancer can be one part of familial cancer syndromes. A well-known example is the family of Napoleon since the Emperor himself as well as his father and his grandfather had gastric cancer. Generally, hereditary factors include germline mutations of E-cadherin, APC, p53 or mismatch repair genes like hMLH1 or hMSH2. Gatekeeper genes like Ecadherin and APC encode signaling proteins important to cellular proliferation and differentiation while protein products from caretaker genes like p53 or mismatch repair genes are important to maintain the integrality and fidelity of the genome. In addition to gene mutations, gene polymorphisms have been shown to be associated with the susceptibility of gastric cancer (El-Omar et al., 2000; Persson et al., 2011). Interestingly, most of these genes are encoding proinflammatory cytokines, strongly indicating the importance of inflammation to the initiation and progression of gastric cancer. Environment factors play important roles in the pathogenesis of gastric cancer by affecting the inflammation in the stomach. The infection of Helicobacter pylori is apparently one of the primary risk factors of gastric cancer. In 1994, the World Health Organization and the International Agency for Research on Cancer Consensus group classified H. pylori as a type I carcinogen in human beings. Although numerous studies reported the growth promoting effect of H. pylori or its derived proteins in vitro, no direct evidence about the interaction of H. pylori with cancer initiating or stem cells have been presented. In contrast, accumulating reports indicated that the inflammation induced by H. pylori infection is the key to gastric carcinogenesis. Thus, it was believed that H. pylori infection is the initial step in the stepwise process of gastric carcinogenesis starting from chronic gastritis, gastric atrophy, intestinal metaplasia, dysplasia to gastric carcinoma. Consistently, diets rich in fruit and vegetables is protective factors of gastric cancer since vitamin C are helpful to attenuate inflammation while inflammation-promoting factors such as smoking, foods with high salts and nitrite could facilitate the development of gastric cancer by promoting chronic inflammation. Microenvironments in chronic inflammatory tissues are rich in growth factors and cytokines important to promote the perpetuation of tumor growth by epigenetically reprogramming cancer stem cells. In addition, there are some DNA damage inducing agents such as reactive oxygen and nitrogen species (RONS) that can cause genomic alterations, promoting the accumulation of mutations in proliferating cancer stem cells (Meira et al., 2008). On the other
Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models

Aya M Westbrook,Akos Szakmary,Robert H Schiestl

DOI: https://doi.org/10.1016/j.mrrev.2010.03.001

Abstract:Chronic inflammation is strongly associated with approximately 1/5th of all human cancers. Arising from combinations of factors such as environmental exposures, diet, inherited gene polymorphisms, infections, or from dysfunctions of the immune response, chronic inflammation begins as an attempt of the body to remove injurious stimuli; however, over time, this results in continuous tissue destruction and promotion and maintenance of carcinogenesis. Here we focus on intestinal inflammation and its associated cancers, a group of diseases on the rise and affecting millions of people worldwide. Intestinal inflammation can be widely grouped into inflammatory bowel diseases (ulcerative colitis and Crohn's disease) and celiac disease. Long-standing intestinal inflammation is associated with colorectal cancer and small-bowel adenocarcinoma, as well as extraintestinal manifestations, including lymphomas and autoimmune diseases. This article highlights potential mechanisms of pathogenesis in inflammatory bowel diseases and celiac disease, as well as those involved in the progression to associated cancers, most of which have been identified from studies utilizing mouse models of intestinal inflammation. Mouse models of intestinal inflammation can be widely grouped into chemically induced models; genetic models, which make up the bulk of the studied models; adoptive transfer models; and spontaneous models. Studies in these models have lead to the understanding that persistent antigen exposure in the intestinal lumen, in combination with loss of epithelial barrier function, and dysfunction and dysregulation of the innate and adaptive immune responses lead to chronic intestinal inflammation. Transcriptional changes in this environment leading to cell survival, hyperplasia, promotion of angiogenesis, persistent DNA damage, or insufficient repair of DNA damage due to an excess of proinflammatory mediators are then thought to lead to sustained malignant transformation. With regards to extraintestinal manifestations such as lymphoma, however, more suitable models are required to further investigate the complex and heterogeneous mechanisms that may be at play.
Role of Inflammation in the Development of Colorectal Cancer

Sridhar Muthusami,Ileng Kumaran Ramachandran,Kokelavani Nampalli Babu,Sneha Krishnamoorthy,Akash Guruswamy,Lurdes Queimado,Gautam Chaudhuri,Ilangovan Ramachandran

DOI: https://doi.org/10.2174/1871530320666200909092908

Abstract:Chronic inflammation can lead to the development of many diseases, including cancer. Inflammatory bowel disease (IBD) that includes both ulcerative colitis (UC) and Crohnmp's disease (CD) are risk factors for the development of colorectal cancer (CRC). Many cytokines produced primarily by the gut immune cells either during or in response to localized inflammation in the colon and rectum are known to stimulate the complex interactions between the different cell types in the gut environment resulting in acute inflammation. Subsequently, chronic inflammation, together with genetic and epigenetic changes, have been shown to lead to the development and progression of CRC. Various cell types present in the colon, such as enterocytes, Paneth cells, goblet cells, and macrophages, express receptors for inflammatory cytokines and respond to tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), IL-6, and other cytokines. Among the several cytokines produced, TNF-α and IL-1β are the key pro-inflammatory molecules that play critical roles in the development of CRC. The current review is intended to consolidate the published findings to focus on the role of pro-inflammatory cytokines, namely TNF-α and IL-1β, on inflammation (and the altered immune response) in the gut, to better understand the development of CRC in IBD, using various experimental model systems, preclinical and clinical studies. Moreover, this review also highlights the current therapeutic strategies available (monotherapy and combination therapy) to alleviate the symptoms or treat inflammation-associated CRC by using monoclonal antibodies or aptamers to block pro-inflammatory molecules, inhibitors of tyrosine kinases in the inflammatory signaling cascade, competitive inhibitors of pro-inflammatory molecules, and the nucleic acid drugs like small activating RNAs (saRNAs) or microRNA (miRNA) mimics to activate tumor suppressor or repress oncogene/pro-inflammatory cytokine gene expression.
Inflammation, DNA methylation and colitis-associated cancer

Lori Hartnett,Laurence J Egan

DOI: https://doi.org/10.1093/carcin/bgs006

Carcinogenesis

Abstract:Inflammation can result from a range of sources including microbial infections, exposure to allergens and toxic chemicals, autoimmune disease and obesity. A well-balanced immune response can be anti-tumorigenic; however, a sustained or chronic inflammatory response is generally harmful as the immune response becomes distorted. A causal link between chronic inflammation and cancer is now well accepted and many chronically inflamed organs of the gastrointestinal tract show this association. For example, patients with inflammatory bowel disease (IBD), including both ulcerative colitis and Crohn's disease, have a 2- to 3-fold greater lifetime risk of developing colorectal cancer compared with the general population. The development of colitis-associated cancer (CAC) is thought to be multifaceted and is probably due to a combination of genetic factors, epigenetic factors and the duration, extent and severity of disease. Recently, epigenetic alterations, in particular alterations in DNA methylation, have been observed during inflammation and inflammation-associated carcinogenesis. The mediators of this, the significance of these changes in DNA methylation and the effect this has on gene expression and the malignant transformation of the epithelial cells during IBD and CAC are discussed in this review. The recent advances in technologies to study genome-wide DNA methylation and the therapeutic potential of understanding these molecular mechanisms are also highlighted.
Chronic Inflammation and Cytokines in the Tumor Microenvironment

Glauben Landskron,Marjorie De la Fuente,Peti Thuwajit,Chanitra Thuwajit,Marcela A. Hermoso

DOI: https://doi.org/10.1155/2014/149185

IF: 4.4929

2014-01-01

Journal of Immunology Research

Abstract:Acute inflammation is a response to an alteration induced by a pathogen or a physical or chemical insult, which functions to eliminate the source of the damage and restore homeostasis to the affected tissue. However, chronic inflammation triggers cellular events that can promote malignant transformation of cells and carcinogenesis. Several inflammatory mediators, such as TNF- α , IL-6, TGF- β , and IL-10, have been shown to participate in both the initiation and progression of cancer. In this review, we explore the role of these cytokines in important events of carcinogenesis, such as their capacity to generate reactive oxygen and nitrogen species, their potential mutagenic effect, and their involvement in mechanisms for epithelial mesenchymal transition, angiogenesis, and metastasis. Finally, we will provide an in-depth analysis of the participation of these cytokines in two types of cancer attributable to chronic inflammatory disease: colitis-associated colorectal cancer and cholangiocarcinoma.

immunology
Mouse models of intestinal inflammation and cancer

Aya M Westbrook,Akos Szakmary,Robert H Schiestl

DOI: https://doi.org/10.1007/s00204-016-1747-2

Abstract:Chronic inflammation is strongly associated with approximately one-fifth of all human cancers. Arising from combinations of factors such as environmental exposures, diet, inherited gene polymorphisms, infections, or from dysfunctions of the immune response, chronic inflammation begins as an attempt of the body to remove injurious stimuli; however, over time, this results in continuous tissue destruction and promotion and maintenance of carcinogenesis. Here, we focus on intestinal inflammation and its associated cancers, a group of diseases on the rise and affecting millions of people worldwide. Intestinal inflammation can be widely grouped into inflammatory bowel diseases (ulcerative colitis and Crohn's disease) and celiac disease. Long-standing intestinal inflammation is associated with colorectal cancer and small-bowel adenocarcinoma, as well as extraintestinal manifestations, including lymphomas and autoimmune diseases. This article highlights potential mechanisms of pathogenesis in inflammatory bowel diseases and celiac disease, as well as those involved in the progression to associated cancers, most of which have been identified from studies utilizing mouse models of intestinal inflammation. Mouse models of intestinal inflammation can be widely grouped into chemically induced models; genetic models, which make up the bulk of the studied models; adoptive transfer models; and spontaneous models. Studies in these models have lead to the understanding that persistent antigen exposure in the intestinal lumen, in combination with loss of epithelial barrier function, and dysfunction and dysregulation of the innate and adaptive immune responses lead to chronic intestinal inflammation. Transcriptional changes in this environment leading to cell survival, hyperplasia, promotion of angiogenesis, persistent DNA damage, or insufficient repair of DNA damage due to an excess of proinflammatory mediators are then thought to lead to sustained malignant transformation. With regard to extraintestinal manifestations such as lymphoma, however, more suitable models are required to further investigate the complex and heterogeneous mechanisms that may be at play.
Inflammation and colorectal cancer: colitis-associated neoplasia

Sergei I. Grivennikov

DOI: https://doi.org/10.1007/s00281-012-0352-6

2012-11-16

Seminars in Immunopathology

Abstract:Connection between inflammation and cancer is a rapidly developing field. Epidemiological data suggests that inflammation along with distinct arms of host immune system plays a very important role in the development and progression of many different cancers. Inflammatory bowel disease (IBD) is an important risk factor for the development of colon cancer, namely, colitis-associated cancer (CAC). The molecular mechanisms by which inflammation promotes cancer development are still being uncovered and may differ between CAC and other forms of colorectal cancer. Recent work has shed light on the role of distinct immune cells, cytokines, and other immune mediators in virtually all of the steps of colonic tumorigenesis, including tumor initiation and promotion as well as progression and metastasis. The close proximity of colonic tumors to the myriad of intestinal microbes, as well as instrumental role of microbiota in IBD, introduces microbes as new players capable of triggering inflammation and possibly promoting tumorigenesis. Various mechanisms of CAC tumorigenesis as well as new possible hints for the future approaches for prevention and therapy are discussed in this review.

pathology,immunology
Inflammation-Induced Tumorigenesis and Metastasis

Sana Hibino,Tetsuro Kawazoe,Hidenori Kasahara,Shinji Itoh,Takatsugu Ishimoto,Mamiko Sakata-Yanagimoto,Koji Taniguchi

DOI: https://doi.org/10.3390/ijms22115421

IF: 5.6

2021-05-21

International Journal of Molecular Sciences

Abstract:Inflammation, especially chronic inflammation, plays a pivotal role in tumorigenesis and metastasis through various mechanisms and is now recognized as a hallmark of cancer and an attractive therapeutic target in cancer. In this review, we discuss recent advances in molecular mechanisms of how inflammation promotes tumorigenesis and metastasis and suppresses anti-tumor immunity in various types of solid tumors, including esophageal, gastric, colorectal, liver, and pancreatic cancer as well as hematopoietic malignancies.

biochemistry & molecular biology,chemistry, multidisciplinary
Tumor-Elicited Inflammation and Colorectal Cancer

Kepeng Wang,Michael Karin

DOI: https://doi.org/10.1016/bs.acr.2015.04.014

2015-01-01

Advances in Cancer Research

Abstract:The link between chronic inflammation and cancer has long been suspected, due to the pioneering work of Rudolf Virchow over 150 years ago. Yet the causal relationship between inflammation and cancer was only deciphered in the past decade or so, using animal models of various cancers. Up to 20% of all human cancers result from chronic inflammation and persistent infections. Proinflammatory cytokines and tumor-infiltrating myeloid and immune cells play critical roles in almost every developmental stages of inflammation-induced cancers, from initiation, promotion, and progression to malignant metastasis. However, even in cancers with no preceding inflammation, inflammatory cells infiltrate tumor stroma and contribute to cancer development. Such "tumor-elicited inflammation" further emphasizes the importance of inflammation in different types of cancers, including that of the colon. In this review, we summarize our current knowledge of the function and induction mechanisms of inflammatory cytokines during colorectal cancer development, and hope to provide insight into the development of novel anticancer therapies by modulating tumor-elicited inflammation.

oncology
Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development

Hsiang-Wei Huang,Cheng-Chih Chang,Chia-Siu Wang,Kwang-Huei Lin

DOI: https://doi.org/10.3390/cells10010067

IF: 6

2021-01-04

Cells

Abstract:Gastrointestinal cancer is highly associated with inflammatory processes inducing the release of cytokines from cancer or immune cells, including interferons, interleukins, chemokines, colony-stimulating factors, and growth factors, which promote or suppress tumor progression. Inflammatory cytokines within the tumor microenvironment promote immune cell infiltration. Infiltrating immune, and tumor-surrounding stromal cells support tumor growth, angiogenesis, metastasis, and immunosuppression through communication with inflammatory cytokines and cell adhesion molecules. Notably, infiltrating immune and tumor cells present immunosuppressive molecules, such as programmed death-ligand 1 (PD-L1) and CD80/CD86. Suppression of cytotoxic T cells promotes tumor avoidance of immune surveillance and greater malignancy. Moreover, glycosylation and sialylation of proteins hyperexpressed on the cancer cell surface have been shown to enhance immune escape and metastasis. Cytokine treatments and immune checkpoint inhibitors are widely used in clinical practice. However, the tumor microenvironment is a rapidly changing milieu involving several factors. In this review, we have provided a summary of the interactions of inflammation and cell adhesion molecules between cancer and other cell types, to improve understanding of the tumor microenvironment.

cell biology
Colitis and cancer: a tale of inflammatory cells and their cytokines

Ezra Burstein,Eric R Fearon

DOI: https://doi.org/10.1172/JCI34831

Abstract:Chronic inflammatory disorders are often associated with an increased cancer risk. A particularly striking example of the chronic inflammation-cancer link is seen in inflammatory bowel disease, in which chronic colitis or persistent inflammation in the colon is associated with elevated risk of colorectal cancer. Animal models exploring the mechanisms by which inflammation increases the risk of colon cancer have shown that inflammatory cells, through the effects of the cytokines they produce, have a major role in promoting neoplastic transformation. In this issue of the JCI, Popivanova and colleagues demonstrate that TNF-alpha, through its effects on the immune system, plays a critical role in promoting neoplastic transformation in this setting (see the related article beginning on page 560). Importantly, the study also provides evidence that anti-TNF-alpha therapies, which are currently in clinical use, may interrupt the process.
Toll-Like Receptor 4 Signaling Integrates Intestinal Inflammation with Tumorigenesis: Lessons from the Murine Model of Colitis-Associated Cancer

Yasmin Hernandez,John Sotolongo,Masayuki Fukata

DOI: https://doi.org/10.3390/cancers3033104

2011-08-02

Cancers

Abstract:Chronic inflammation has long been implicated as a predisposition for cancer, but the underlying mechanism for how this occurs has remained obscure. Ulcerative colitis (UC) is a chronic inflammatory disorder of the large intestine which is known to be highly linked to colorectal cancer. During chronic inflammation the intestinal mucosa is in a constant cycle of injury and repair resulting in aberrant epithelial proliferation, a process that increases the risk of neoplastic transformation. In particular, the coexistence of commensal flora in the intestine plays an important role in the regulation of mucosal restitution after epithelial injury. It has become apparent that signaling through toll-like receptors (TLRs), the receptor family recognizing pathogen-associated molecular patterns, is crucial to intestinal epithelial proliferation and mucosal restitution. We have recently described two important downstream pathways underlying TLR4-mediated epithelial proliferation in a mouse model of colitis-associated cancer; i.e., cyclooxygenase 2 (COX-2)-mediated production of prostaglandin E2 (PGE2), and induction of specific ligands for epidermal growth factor receptor (EGFR). These two pathways are closely involved with mucosal levels of PGE2 and other prostanoids such as 15-deoxy-delta 12,14-prostaglandin-J2 (15d-PGJ2). Understanding the fine interplay between the TLR signaling and intestinal tumorigenesis in the setting of chronic inflammation can contribute to establishing a novel treatment strategy for inflammation-associated cancers.

oncology
Innate Immunity and Cancer Pathophysiology.

J. Daßler-Plenker,L. Maiorino,M. Egeblad,Lijuan Sun

DOI: https://doi.org/10.1146/annurev-pathmechdis-032221-115501

2021-11-17

Abstract:Chronic inflammation increases the risk of several cancers, including gastric, colon, and hepatic cancers. Conversely, tumors, similar to tissue injury, trigger an inflammatory response coordinated by the innate immune system. Cellular and molecular mediators of inflammation modulate tumor growth directly and by influencing the adaptive immune response. Depending on the balance of immune cell types and signals within the tumor microenvironment, inflammation can support or restrain the tumor. Adding to the complexity, research from the past two decades has revealed that innate immune cells are highly heterogeneous and plastic, with variable phenotypes depending on tumor type, stage, and treatment. The field is now on the cusp of being able to harness this wealth of data to (a) classify tumors on the basis of their immune makeup, with implications for prognosis, treatment choice, and clinical outcome, and (b) design therapeutic strategies that activate antitumor immune responses by targeting innate immune cells. Expected final online publication date for the Annual Review of Pathology: Mechanisms of Disease, Volume 17 is January 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

Medicine,Biology
Crosstalk Between DNA Damage and Inflammation in the Multiple Steps of Gastric Carcinogenesis

Olga Sokolova,Michael Naumann

DOI: https://doi.org/10.1007/978-3-030-15138-6_5

Abstract:Over the last years, intensive investigations in molecular biology and cell physiology extended tremendously the knowledge about the association of inflammation and cancer. In frame of this paradigm, the human pathogen Helicobacter pylori triggers gastritis and gastric ulcer disease, and contributes to the development of gastric cancer. Mechanisms, by which the bacteria-induced inflammation in gastric mucosa leads to intestinal metaplasia and carcinoma, are represented in this review. An altered cell-signaling response and increased production of free radicals by epithelial and immune cells account for the accumulation of DNA damage in gastric mucosa, if infection stays untreated. Host genetics and environmental factors, especially diet, can accelerate the process, which offers the opportunity of intervention based on a balanced nutrition. It is supposed that inflammation might influence stem- or progenitor cells in gastric tissue predisposing for metaplasia or tumor relapse. Herein, DNA is strongly mutated and labile, which restricts therapy options. Thus, the understanding of the mechanisms that underlie gastric carcinogenesis will be of preeminent importance for the development of strategies for screening and early detection. As most gastric cancer patients face late-stage disease with a poor overall survival, the development of multi-targeted therapeutic intervention strategies is a major challenge for the future.
Mechanisms of Immune Signaling in Colitis-Associated Cancer

Maximilian J Waldner,Markus F Neurath

DOI: https://doi.org/10.1016/j.jcmgh.2014.11.006

2014-12-12

Abstract:The inflammatory bowel diseases ulcerative colitis and Crohn's disease are associated with an increased risk for the development of colorectal cancer. During recent years, several immune signaling pathways have been linked to colitis-associated cancer (CAC), largely owing to the availability of suitable preclinical models. Among these, chronic intestinal inflammation has been shown to support tumor initiation through oxidative stress-induced mutations. A proinflammatory microenvironment that develops, possibly as a result of defective intestinal barrier function and host-microbial interactions, enables tumor promotion. Several molecular pathways such as tumor necrosis factor/nuclear factor-κB or interleukin 6/signal transducer and activator of transcription 3 signaling have been identified as important contributors to CAC development and could be promising therapeutic targets for the prevention and treatment of CAC.
Proximal Gastric Vagotomy without “Drainage”: An Experimental Study

C. A. Hallenbeck,J. Gleysteen

DOI: https://doi.org/10.1097/00000658-197405000-00013

IF: 13.787

1974-05-01

Annals of Surgery

Abstract:
Mutation-promoting molecular networks of uncontrolled inflammation

Hui Zhang,Xuanfu Xu

DOI: https://doi.org/10.1177/1010428317701310

2017-06-01

Tumor Biology

Abstract:More and more studies show that chronic inflammation can lead to tumor formation. The complex interactions of inflammatory cells, stroma and tumor parenchymal cell are closely related to tumor formation. Under the state of chronic inflammatory microenvironment, long-term interaction of inflammatory cells and stromal cells as well as the parenchymal cells makes signaling pathway in parenchyma cells disordered. A series of gene level editor modification, epigenetic changes, and the regulation of transcription and translation changes will happen based on signaling pathway disorder. The changes ultimately lead to cell mutations and phenotypic transformation occurred. Recent findings provide an objective basis for cancer treatment and prevention. However, further discusses at the core of the possible molecular in tumor formation provide a theoretical foundation for future study of the pathogenesis and molecular targeted therapy of cancer. This review summarizes the research in the field of chronic inflammation and cancer in recent years, and analyze the molecules network in the process of the carcinogenic inflammation comprehensively. Beyond that, this review intends to describe possible carcinogenic inflammation core molecular and provides a theoretical basis for future study of the pathogenesis, chemoprevention and molecular targeted therapy of cancer.
Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation

Georgios S Markopoulos,Eugenia Roupakia,Kenneth B Marcu,Evangelos Kolettas

DOI: https://doi.org/10.3390/cells8101143

IF: 6

2019-09-25

Cells

Abstract:The neoplastic transformation of normal to metastatic cancer cells is a complex multistep process involving the progressive accumulation of interacting genetic and epigenetic changes that alter gene function and affect cell physiology and homeostasis. Epigenetic changes including DNA methylation, histone modifications and changes in noncoding RNA expression, and deregulation of epigenetic processes can alter gene expression during the multistep process of carcinogenesis. Cancer progression and metastasis through an 'invasion-metastasis cascade' involving an epithelial-to-mesenchymal cell transition (EMT), the generation of cancer stem cells (CSCs), invasion of adjacent tissues, and dissemination are fueled by inflammation, which is considered a hallmark of cancer. Chronic inflammation is generated by inflammatory cytokines secreted by the tumor and the tumor-associated cells within the tumor microenvironment. Inflammatory cytokine signaling initiates signaling pathways leading to the activation of master transcription factors (TFs) such as Smads, STAT3, and NF-κB. Moreover, the same inflammatory responses also activate EMT-inducing TF (EMT-TF) families such as Snail, Twist, and Zeb, and epigenetic regulators including DNA and histone modifying enzymes and micoRNAs, through complex interconnected positive and negative feedback loops to regulate EMT and CSC generation. Here, we review the molecular regulatory feedback loops and networks involved in inflammatory cytokine-induced EMT and CSC generation.

Is continuous warm retrograde blood cardioplegia completely safe for coronary artery surgery?

Chronic inflammation and gastrointestinal cancer

From Inflammation to Cancer: the Molecular Basis

The Epigenetic Aspects of Gastric Cancer

Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models

Role of Inflammation in the Development of Colorectal Cancer

Inflammation, DNA methylation and colitis-associated cancer

Chronic Inflammation and Cytokines in the Tumor Microenvironment

Mouse models of intestinal inflammation and cancer

Inflammation and colorectal cancer: colitis-associated neoplasia

Inflammation-Induced Tumorigenesis and Metastasis

Tumor-Elicited Inflammation and Colorectal Cancer

Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development

Colitis and cancer: a tale of inflammatory cells and their cytokines

Toll-Like Receptor 4 Signaling Integrates Intestinal Inflammation with Tumorigenesis: Lessons from the Murine Model of Colitis-Associated Cancer

Innate Immunity and Cancer Pathophysiology.

Crosstalk Between DNA Damage and Inflammation in the Multiple Steps of Gastric Carcinogenesis

Mechanisms of Immune Signaling in Colitis-Associated Cancer

Proximal Gastric Vagotomy without “Drainage”: An Experimental Study

Mutation-promoting molecular networks of uncontrolled inflammation

Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation